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Gender-Specific Associations of Short Sleep Duration With
Prevalent and Incident Hypertension
The Whitehall II Study
Francesco P. Cappuccio, Saverio Stranges, Ngianga-Bakwin Kandala, Michelle A. Miller,
Frances M. Taggart, Meena Kumari, Jane E. Ferrie, Martin J. Shipley,
Eric J. Brunner, Michael G. Marmot
Abstract—Sleep deprivation (5 hour per night) was associated with a higher risk of hypertension in middle-aged
American adults but not among older individuals. However, the outcome was based on self-reported diagnosis of
incident hypertension, and no gender-specific analyses were included. We examined cross-sectional and prospective
associations of sleep duration with prevalent and incident hypertension in a cohort of 10 308 British civil servants aged
35 to 55 years at baseline (phase 1: 1985–1988). Data were gathered from phase 5 (1997–1999) and phase 7
(2003–2004). Sleep duration and other covariates were assessed at phase 5. At both examinations, hypertension was
defined as blood pressure 140/90 mm Hg or regular use of antihypertensive medications. In cross-sectional analyses
at phase 5 (n5766), short duration of sleep (5 hour per night) was associated with higher risk of hypertension
compared with the group sleeping 7 hours, among women (odds ratio: 2.01; 95% CI: 1.13 to 3.58), independent of
confounders, with an inverse linear trend across decreasing hours of sleep (P0.003). No association was detected in
men. In prospective analyses (mean follow-up: 5 years), the cumulative incidence of hypertension was 20.0% (n740)
among 3691 normotensive individuals at phase 5. In women, short duration of sleep was associated with a higher risk
of hypertension in a reduced model (age and employment) (6 hours per night: odds ratio: 1.56 [95% CI: 1.07 to 2.27];
5 hour per night: odds ratio: 1.94 [95% CI: 1.08 to 3.50] versus 7 hours). The associations were attenuated after
accounting for cardiovascular risk factors and psychiatric comorbidities (odds ratio: 1.42 [95% CI: 0.94 to 2.16]; odds
ratio: 1.31 [95% CI: 0.65 to 2.63], respectively). Sleep deprivation may produce detrimental cardiovascular effects
among women. (Hypertension. 2007;50:694-701.)
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Sleep-disordered breathing (SDB) has been linked toelevated blood pressure and risk of hypertension in
several epidemiological observational studies.1–5 Growing
evidence indicates that sleep deprivation is also associated
with a number of health outcomes, including hyperten-
sion.6–14 For example, in a recent longitudinal analysis of the
first National Health And Nutrition Examination Survey
(NHANES-I), short sleep duration (5 hours per night) was
associated with a 60% higher risk of incident hypertension in
middle-aged (32 to 59 years) American adults without appar-
ent sleep disorders during a mean follow-up of 8 to 10
years.13 No association was found in individuals60 years of
age. However, the outcome was based on self-reported
diagnosis of incident hypertension, and no gender-specific
analyses were included. Furthermore, a cross-sectional anal-
ysis from the Sleep Heart Health Study on a sample of6000
US adults showed a significant higher prevalence of hyper-
tension among individuals with usual sleep duration above
or below the median of 7 to 8 hours per night.14 The
association was stronger, ie, a 66% higher risk of hyperten-
sion, among short sleepers (6 hours per night). Although
this study attempted to account for a number of potential
confounders, including psychiatric and cardiovascular comor-
bidities, the cross-sectional design did not allow inference on
the temporal relationship between sleep duration and
hypertension.
Several studies in humans indicate potential pathophysio-
logical mechanisms supporting the biological plausibility of
the association between sleep deprivation and hypertension.
For example, acute curtailments of sleep may induce an
overactivity of the sympathetic nervous system leading to
higher blood pressure in both normotensive and hypertensive
individuals.15–17 Other contributing mechanisms may include
overactivity of the renin-angiotensin-aldosterone system,
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proinflammatory responses, endothelial dysfunction, and re-
nal impairment.18,19 On the other hand, intervention studies to
improve duration and quality of sleep have been effective in
reducing both daytime and nighttime blood pressures.19,20
However, there is concern that sleep habits may represent a
marker of health status and quality of life rather than a casual
factor for hypertension and other health outcomes.21
In the present analysis, we sought to examine both the
cross-sectional and prospective associations of sleep duration
with prevalent and incident hypertension in the Whitehall II
Study, a prospective cohort of 10 308 white-collar British
civil servants aged 35 to 55 at baseline (phase 1: 1985–1988).
Because reduced durations of sleep might be associated with
more detrimental effects on cardiovascular outcomes among
women,6–9 unlike previous investigations, we conducted




The Whitehall II Cohort was recruited in 1985–1988 (phase 1) from
20 London-based civil service departments. The rationale, design,
and methods of the study have been described in detail elsewhere.22
Briefly, the initial response rate was 73%, and the final cohort
consisted of 10 308 participants; 3413 women and 6895 men.
Follow-up screening examinations took place in 1991–1993 (phase
3), 1997–1999 (phase 5), and 2003–2004 (phase 7), whereas postal
questionnaires were sent to participants in 1989 (phase 2), 1995
(phase 4), and 2001 (phase 6). The participation rates of the original
cohort (n10 308) were 83%, 76%, and 68% at phases 3, 5, and 7,
respectively. In this report, we used data from phases 5 and 7. The
total sample at phase 5 consisted of 7204 participants. The present
analyses were restricted to white individuals (n6592), given the
low numbers of other ethnic groups (n612). For the cross-sectional
analyses, only participants with a complete set of data at phase 5
were included (n5766: 4199 men and 1567 women). Their char-
acteristics were comparable to the overall sample (see Appendix).
For the longitudinal analyses, the incidence of hypertension at phase
7 was assessed among participants who were normotensive at phase
5 (n3691: 2686 men and 1005 women).
Sleep Duration
At phases 5 and 7, sleep duration was elicited by the question, “How
many hours of sleep do you have on an average week night?”
Response categories were 5 hours, 6 hours, 7 hours, 8 hours, and
9 hours.
Covariates
For the present analyses, age and other covariates were derived from
the questionnaires at phase 5. Employment grade was determined
from the participant’s last known civil service grade title (19% had
retired by phase 5) and divided into 3 categories in order of
decreasing salary: administrative, professional/executive, and cleri-
cal/support. Participants were allocated to 1 of 4 smoking categories:
never, ex-smoker, pipe and/or cigar only, or current cigarette smoker
(manufactured or hand-rolled cigarettes). Alcohol consumption in
the previous week was recorded (units per week). Leisure-time
physical activity was categorized by energy use in 2 categories:
“vigorous” (subjects who reported1.5 hour of vigorous activity per
week) and no vigorous activity. General health status was assessed
using the physical and mental health component summaries of the
Short Form-36 (SF-36) health survey questionnaire23: low scores
indicate low functioning. Psychiatric morbidity, including depres-
sion, was assessed with a modified General Health Questionnaire
score. Participants taking sleep medication (hypnotics) or cardiovas-
cular drugs were identified through a questionnaire item on current
medication. At both phase 5 and 7 screening examinations, anthro-
pometric measures were recorded, including height, weight, and
waist circumference; body mass index (BMI) was calculated as
weight in kilograms divided by height in meters squared. Blood
pressure was measured 3 times using a standard mercury manometer
by trained and certified technicians in both examinations. The onsets
of the first-phase (systolic) and fifth-phase (diastolic) Korotkoff
sounds were recorded. The mean of the second and third measures
were used in the analyses. At both examinations, hypertension was
defined as blood pressure 140/90 mm Hg or regular use of
antihypertensive medications.
Ethical Approval
Ethical approval for the Whitehall II Study was obtained from the
University College London Medical School committee on the ethics
of human research.
Statistical Analysis
For continuous and categorical variables, respectively, Kruskal
Wallis and 2 tests were used to determine the statistical significance
of any difference in the distribution of baseline variables at phase 5
across categories of sleep duration. The statistical significance of the
interaction between each baseline characteristic and sleep duration,
adjusted for other important baseline variables, was tested in multi-
variate logistic regression models that included this interaction and
the corresponding main effect terms. The interaction between sleep
duration and gender was significant (P0.05); therefore, all of the
analyses were stratified by gender. No significant interactions were
found between sleep duration and age or other relevant covariates.
Univariate and multivariate regression analyses were conducted to
test the association between categories of sleep duration and preva-
lent hypertension at phase 5 (cross-sectional analyses), as well as the
association between sleep duration at phase 5 and incident hyper-
tension at phase 7 (prospective analyses). Covariates included the
following: baseline age, employment, alcohol consumption, smok-
ing, physical activity, BMI, cardiovascular disease (CVD) drugs
(other than antihypertensive medications), the SF-36 mental and
physical health component scores, depression, and use of hypnotics.
In these analyses, 7 hours of sleep was selected as the reference
category. All of the techniques were implemented using Stata 9.0.
Results
Descriptives
Characteristics for both male and female participants (Table
1) at phase 5 (baseline) are reported by categories of sleep
duration. Among men, participants sleeping 9 hours were,
on average, older than other participants; in addition, they
were less likely to be physically active and more likely to be
on medication for CVD drugs. On the other hand, male
participants sleeping 5 hours had a lower employment
status, higher mean levels of BMI and waist circumference,
were more likely to be depressed and on medication for
hypnotics, and reported lower scores for mental and physical
health than other participants. No significant differences in
drinking and smoking habits were reported across categories
of sleep duration. For blood pressures, no consistent pattern
of association was noted; however, the mean levels of systolic
blood pressure (and pulse pressure) and the prevalence of
hypertension were significantly higher among participants
sleeping 8 hours than in other participants.
Among women, participants at the 2 extreme categories of
sleep duration (ie, 5 hours and 9 hours) were character-
ized, in general, by a poorer health status and lifestyle profile.
In particular, they had a lower employment status, were less
likely to be physically active, more likely to be on medication
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for CVD drugs or hypnotics, more likely to be depressed, and
reported lower scores for mental and physical health than
other categories. No significant differences in drinking and
smoking habits were reported across categories of sleep
duration. For blood pressures, there was a consistent pattern
of association among female participants sleeping 5 hours,
who reported higher mean levels of systolic blood pressure
(and pulse pressure), as well as a significantly higher preva-
TABLE 1. Baseline Characteristics (Phase 5: 1997–1999) Across Categories of Sleep Duration: The
Whitehall II Study (n5766)
Characteristics
Sleep Duration
P *5 h 6 h 7 h 8 h 9 h
Men (n4199)
No. of subjects 265 1383 1886 620 45
Age, y 54.6 (5.6) 54.6 (5.7) 55.5 (6.1) 57.5 (6.1) 57.7 (5.4) 0.001
DBP, mm Hg 79.2 (10.9) 78.2 (10.4) 78.6 (10.5) 79.0 (10.9) 78.1 (10.6) 0.57
SBP, mm Hg 124.0 (16.7) 122.3 (15.4) 123.9 (15.8) 125.1 (17.3) 122.5 (16.6) 0.009
Pulse pressure, mm Hg 44.7 (11.5) 44.1 (10.7) 45.3 (11.0) 46.1 (12.4) 44.4 (11.1) 0.003
Lowest employment, n (%) 26 (9.8) 66 (4.8) 62 (3.3) 18 (2.9) 3 (6.7) 0.001
BMI, kg/m2 27.0 (4.1) 26.4 (3.5) 25.9 (3.4) 25.4 (3.3) 25.7 (3.3) 0.001
Waist, cm 94.9 (11.6) 92.8 (10.2) 91.6 (9.7) 90.2 (9.9) 91.5 (8.5) 0.001
Weekly alcohol, units 18.0 (21.2) 16.9 (15.9) 16.5 (15.9) 16.3 (17.1) 17.7 (20) 0.58
CVD drugs, n (%) 49 (18.6) 185 (13.4) 259 (13.8) 111 (18.0) 9 (20.0) 0.013
Physical activity, n (%) 108 (40.8) 687 (49.7) 930 (49.3) 320 (51.6) 17 (37.8) 0.022
SF-36 mental (score) 47.1 (12.2) 50.5 (9.2) 52.5 (8.2) 53.7 (7.5) 52.0 (9.9) 0.001
SF-36 physical (score) 50.2 (8.8) 52.1 (7.1) 52.4 (6.4) 51.9 (6.8) 50.9 (8.5) 0.019
Use of hypnotics, n (%) 7 (2.7) 8 (0.6) 4 (0.2) 2 (0.3) 0 (0.0) 0.001
Depression cases, n (%) 62 (23.8) 178 (13.1) 173 (9.3) 55 (9.0) 4 (8.9) 0.001
Current smoking, n (%) 30 (11.5) 123 (8.9) 154 (8.2) 49 (7.9) 4 (8.9) 0.45
Hypertensive, n (%) 84 (31.7) 358 (25.9) 533 (28.3) 205 (33.1) 14 (31.1) 0.014
No medication 45 (17.0) 218 (15.8) 323 (17.1) 115 (18.6) 9 (20.0)   
Medication 38 (14.3)† 140 (10.1) 208 (11.0)‡ 90 (14.5) 5 (11.1)   
Women (n1567)
No. of subjects 157 511 597 272 30
Age, y 56.4 (5.9) 56.1 (6.1) 55.7 (6.1) 56.8 (6.1) 54.7 (5.7) 0.07
DBP, mm Hg 75.7 (10.4) 74.9 (10.1) 74.4 (9.8) 74.2 (10.0) 74.0 (10.0) 0.50
SBP, mm Hg 124.2 (18.3) 121.2 (16.8) 120.3 (17.1) 121.4 (16.8) 118 (17.2) 0.07
Pulse pressure, mm Hg 48.5 (13.8) 46.3 (12.3) 45.9 (12.3) 47.2 (11.6) 44.0 (10.9) 0.07
Lowest employment, n (%) 52 (33.1) 143 (28.1) 162 (27.2) 67 (25.0) 11 (36.7) 0.003
BMI, kg/m2 27.1 (5.8) 26.2 (5.1) 25.9 (4.4) 26.3 (5.0) 25.8 (4.6) 0.31
Waist, cm 82.5 (14.3) 80.2 (11.8) 80.1 (11.2) 80.4 (11.9) 81.5 (12.0) 0.66
Weekly alcohol, units 7.3 (10.8) 8.0 (8.5) 8.2 (9.5) 8.4 (10.0) 9.8 (9.4) 0.10
CVD drugs, n (%) 36 (23.1) 58 (11.4) 94 (15.8) 46 (16.9) 4 (13.3) 0.007
Physical activity, n (%) 38 (24.2) 169 (33.1) 215 (36) 108 (39.7) 6 (20.0) 0.006
SF-36 mental (score) 42.9 (13.1) 49.0 (10.3) 50.8 (9.2) 52.6 (8.8) 46.9 (15.0) 0.001
SF-36 physical (score) 46.0 (12.5) 50.2 (8.4) 49.8 (9.0) 49.9 (8.8) 45.2 (10.1) 0.001
Use of hypnotics, n (%) 2 (1.3) 5 (1.0) 4 (0.7) 2 (0.7) 1 (3.3) 0.60
Depression cases, n (%) 50 (32.5) 72 (14.4) 66 (11.2) 20 (7.4) 5 (16.7) 0.001
Current smoking, n (%) 20 (12.9) 79 (15.5) 76 (12.8) 31 (11.4) 1 (3.3) 0.22
Hypertensive, n (%) 58 (36.9) 124 (24.3) 152 (25.5) 66 (24.3) 7 (23.3) 0.024
No medication 27 (17.2) 72 (14.1) 69 (11.6) 29 (10.7) 5 (16.7)   
Medication 31 (19.7) 52 (10.2) 83 (13.9) 37 (13.6) 2 (6.7)   
Data are expressed as the mean (SD) or as n (%). DBP indicates diastolic blood pressure; SBP, systolic blood pressure.
*P value for comparison across sleep duration groups using the 2 analysis for categorical variables and Kruskal-Wallis test for
continuous variables.
†One value is missing.
‡Two values are missing.
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lence of hypertension than other participants (in both treated
and untreated individuals).
Cross-Sectional Analysis
Table 2 displays the odds ratios (ORs) and 95% CIs of
prevalent hypertension across categories of sleep duration at
phase 5, using 7 hours of sleep as the reference category.
Among men, no consistent pattern of association was noted.
Among women, in fully adjusted analyses, short duration of
sleep (5 hours per night) was associated with a significantly
higher risk of hypertension compared with the group sleeping
7 hours (OR: 2.01; 95% CI: 1.13 to 3.58), independent of
several potential confounders, with a significant inverse
linear trend across decreasing hours of sleep (P0.003).
Prospective Analysis
Table 3 displays the ORs (and 95% CIs) of incident hyper-
tension at phase 7 among participants who were normoten-
sive at phase 5. During a mean follow-up of 5 years, the
cumulative incidence of hypertension was 20.0% (740 of
TABLE 2. OR (95% CI) of Prevalent Hypertension Across Categories of Sleep Duration at Phase 5 (1997–1999): The Whitehall II Study
(n5766)
Sample Models
Sleep Duration P *
5 h 6 h 7 h 8 h 9 h Linear Nonlinear
Men (n4199)
No. 265 1383 1886 620 45      
Cases, n 84 358 533 205 14      
Model 1‡ 1.18 0.89 1.55 0.89 0.76 1.04 1 1.25† 1.03 1.52 1.15 0.61 2.17 0.06 0.015
Model 2§ 1.23 0.92 1.63 0.93 0.79 1.09 1 1.11 0.91 1.36 0.99 0.52 1.90 0.70 0.09
Model 3¶ 0.88 0.63 1.23 0.86 0.72 1.03 1 1.12 0.89 1.41 0.92 0.44 1.92 0.05 0.54
Women (n1567)
No. 157 511 597 272 30   
Cases, n 58 124 152 66 7   
Model 1‡ 1.72† 1.18 2.49 0.94 0.71 1.23 1 0.94 0.67 1.31 0.89 0.37 2.12 0.13 0.06
Model 2§ 1.64† 1.11 2.42 0.90 0.68 1.19 1 0.83 0.58 1.17 0.98 0.40 2.40 0.12 0.15
Model 3¶ 1.72† 1.07 2.75 0.92 0.67 1.28 1 0.74 0.50 1.11 0.70 0.21 2.37 0.037† 0.31
*P value for test of linear and nonlinear trends.
†P0.05.
‡Model 1: unadjusted.
§Model 2: adjusted for age and employment.
¶Model 3: model 2alcohol consumption, smoking, physical activity, BMI, SF-36 mental, SF-36 physical, depression cases, hypnotics use, and CVD drugs.
TABLE 3. OR (95% CI) of Incident Hypertension at Phase 7 (2002–2003) Across Categories of Sleep Duration at Phase 5
(1997–1999): The Whitehall II Study (n3691)
Sample Models
Sleep Duration P *
5 h 6 h 7 h 8 h 9 h Linear Nonlinear
Men (n2686)
No. 160 900 1224 372 30
Cases, n 29 179 243 85 3
Model 1‡ 0.89 0.58 1.37 1.00 0.81 1.24 1 1.20 0.90 1.58 0.45 0.13 1.49 0.60 0.53
Model 2§ 0.96 0.62 1.48 1.07 0.86 1.34 1 1.07 0.80 1.42 0.36 0.11 1.19 0.51 0.42
Model 3¶ 0.89 0.55 1.43 1.02 0.80 1.31 1 1.11 0.80 1.53 0.13† 0.02 0.98 0.55 0.18
Women (n1005)
No. 75 330 394 186 20
Cases, n 20 77 64 37 3
Model 1‡ 1.88† 1.05 3.34 1.56† 1.08 2.27 1 1.28 0.82 2.01 0.91 0.26 3.20 0.029† 0.38
Model 2§ 1.94† 1.08 3.50 1.56† 1.07 2.27 1 1.17 0.74 1.86 0.92 0.26 3.27 0.015† 0.42
Model 3¶ 1.31 0.65 2.63 1.42 0.93 2.16 1 0.99 0.59 1.69 1.07 0.29 3.94 0.12 0.61
*P value for test of linear and nonlinear trends.
†P0.05.
‡Model 1: unadjusted.
§Model 2: adjusted for age and employment.
¶Model 3: model 2alcohol consumption, smoking, physical activity, BMI, SF-36 mental, SF-36 physical, depression cases, hypnotics use, and CVD drugs.
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3691 total: 539 of 2686 in men and 201 of 1005 in women).
Among men, no consistent pattern of association was seen
across categories of sleep duration. Among women, short
duration of sleep was associated with significantly higher
risks of hypertension compared with the group sleeping 7
hours in unadjusted analyses, as well as in a reduced model
(age and employment; 6 hours per night: OR: 1.56 [95% CI:
1.07 to 2.27], 5 hours per night: OR: 1.94 [95% CI: 1.08 to
3.50]). However, these associations were attenuated after
accounting for cardiovascular risk factors and psychiatric
comorbidities (OR: 1.42 [95% CI: 0.94 to 2.16]; OR: 1.30
[95% CI: 0.65 to 2.62], respectively). The proportion of the
variance of the risk of developing hypertension explained by
the age- and employment-adjusted model was 2.95%. In the
fully adjusted model it was 6.14%. The major contributor in
the full multivariate model was body mass index (explaining
2.23% of the added variance), whereas the remaining covari-
ates all accounted for 1% of the remaining difference.
Results were virtually unchanged after further adjustment for
the baseline values of systolic blood pressure (data not
shown).
Other Analyses
We also carried out linear regression analyses to test the
association between sleep duration and blood pressures (sys-
tolic, diastolic, and pulse pressures) at phase 5 (cross-
sectional analyses), as well as the association between sleep
duration at phase 5 and changes in blood pressures between
the 2 phases (prospective analyses), among participants not
taking antihypertensive medications. In cross-sectional anal-
yses, there were consistent, significant inverse associations
(P0.05) between duration of sleep and either systolic blood
pressure (1.24 mm Hg per hour of sleep; 95% CI:
2.23 to 0.24 mm Hg per hour of sleep) or pulse pressure
(0.91 mm Hg per hour of sleep; 95% CI: 1.63 to
0.20 mm Hg per hour of sleep), only among women, in
fully adjusted models. In prospective analyses, no significant
associations were found for any of the blood pressure
measures among either male or female participants (data not
shown).
Discussion
Findings from the Whitehall II cohort showed gender-specific
associations between sleep duration and hypertension. Spe-
APPENDIX. Baseline Characteristics (Phase 5: 1997–1999): The Whitehall II Study
Characteristics
n6592* n5766† n612‡
Men Women Men Women Men Women
No. of subjects 4724 1868 4199 1567 329 283
Age, y 55.6 (6.0) 56.3 (6.1) 55.4 (6.0) 56.1 (6.1) 57.7 (5.9) 56.2 (5.4)
DBP, mm Hg 78.6 (10.6) 74.6 (10.0) 78.6 (10.6) 74.6 (10.0) 79.2 (10.8) 78.5 (10.2)
SBP, mm Hg 123.5 (16.0) 121.1 (17.1) 123.6 (16.0) 121.1 (17.1) 125.6 (17.3) 127.5 (19.1)
Pulse pressure, mm Hg 44.9 (11.2) 46.5 (12.4) 45.0 (11.2) 46.5 (12.3) 46.4 (12.6) 49.0 (14.1)
Sleep duration, n (%)
5 h 296 (6.4) 190 (10.4) 265 (6.3) 157 (10.0) 43 (13.6) 34 (12.8)
6 h 1521 (32.8) 602 (32.9) 1383 (32.9) 511 (32.6) 121 (38.2) 94 (35.3)
7 h 2090 (45.0) 687 (37.6) 1886 (44.9) 597 (38.1) 95 (30.0) 101 (38.0)
8 h 683 (14.7) 310 (17.0) 620 (14.8) 272 (17.4) 45 (14.2) 31 (11.7)
9 h 53 (1.1) 40 (2.2) 45 (1.1) 30 (1.9) 13 (4.1) 6 (2.3)
Lowest employment grade, n (%) 207 (4.4) 545 (29.5) 175 (4.2) 435 (27.9) 65 (19.8) 181 (64.4)
BMI, kg/m2 26.1 (3.5) 26.2 (4.9) 26.0 (3.5) 26.2 (4.9) 25.7 (3.2) 28.1 (5.1)
Waist, cm 92.1 (10.1) 80.4 (11.9) 92.0 (10.1) 80.5 (11.9) 90.6 (9.0) 85.1 (11.4)
Weekly alcohol, units 16.7 (16.6) 7.8 (9.5) 16.7 (16.5) 8.1 (9.6) 10.3 (18.3) 2.7 (5.4)
CVD drugs, n (%) 719 (15.3) 299 (16.1) 613 (14.6) 238 (15.2) 89 (27.2) 93 (32.9)
Physical activity, n (%) 2277 (48.2) 601 (32.2) 2062 (49.1) 536 (34.2) 99 (30.1) 47 (16.6)
SF-36 mental, score 51.6 (9.0) 49.7 (10.4) 51.7 (8.9) 49.7 (10.4) 50.0 (10.4) 49.1 (10.8)
SF-36 physical, score 60.0 (7.1) 49.1 (9.6) 52.1 (6.9) 49.5 (9.3) 49.2 (8.7) 44.5 (10.4)
Use of hypnotics, n (%) 26 (0.55) 17 (0.9) 21 (0.5) 14 (0.9) 2 (0.6) 0 (0.0)
Depression cases, n (%) 545 (11.8) 255 (14.1) 472 (11.4) 213 (13.8) 66 (21.4) 57 (22.2)
Current smoking, n (%) 436 (9.3) 266 (14.3) 360 (8.6) 207 (13.3) 40 (12.3) 13 (4.63)
Male hypertensive, n (%) 1194 (25.3) 407 (21.8) 1194 (28.4) 407 (26.0) 110 (33.4) 117 (41.3)
No medication 630 (13.3) 153 (8.2) 713 (17.0) 202 (12.9) 35 (10.6) 32 (11.3)
Medication 564 (11.9) 254 (13.6) 481 (11.5) 205 (13.1) 75 (22.8) 85 (30.0)
Data are expressed as the mean (SD) or as n (%).
*n6592 for all white participants.
†n5766 for white participants with complete data on blood pressure.
‡n612 for ethnic minorities excluded from the analysis.
698 Hypertension October 2007
 at UNIVERSITY WARWICK on September 6, 2007 hyper.ahajournals.orgDownloaded from 
cifically, short duration of sleep was associated with higher
risks of prevalent and incident hypertension only among
women. We could not detect consistent associations among
men or for long duration of sleep. For the latter finding, it
should be noted, however, that there were very few individ-
uals (1.3% of the overall sample) in our study who reported
sleeping 9 hours per night, thus yielding a limited statistical
power to examine the association between sleep duration and
hypertension in this subgroup. Furthermore, our findings
point to the importance of a comprehensive scrutiny of potential
confounders and mediators when examining the associations
between durations of sleep and health outcomes. In fact, the
observed associations among women were attenuated after
accounting for a number of cardiovascular risk factors, measures
of general health, and psychiatric comorbidities.
A substantial amount of evidence exists about the link
between SDB and hypertension.1–5 The epidemiological data
have been corroborated by findings of mechanistic studies
emphasizing the critical role of sympathetic overactivity in
the etiology of SDB-related hypertension,24,25 although other
mechanisms are likely to be involved.19 More recently, sleep
deprivation has been indicated as a risk factor for several
chronic health outcomes in individuals without overt sleep
disorders.6–12 However, we are aware of only 2 population-
based studies so far, both coming from the United States, that
have attempted to examine the association between self-
reported durations of sleep and risk of hypertension.13,14
Specifically, in a longitudinal analysis of the NHANES-I
(n4810), short sleep duration (5 hours per night) was
associated with a 60% higher risk of incident hypertension, in
fully adjusted models, among middle-aged (32 to 59 years)
American adults without apparent sleep disorders.13 No
association was found in individuals 60 years of age.
However, in this study, the diagnosis of incident hypertension
was based on self-report with a potential of misclassification
(underdiagnosis), as suggested by a lower cumulative inci-
dence (647 of 4810 [13.5%]) as compared with that
observed in our study (740 of 3691 [20.0%]), despite com-
parable age ranges between the 2 studies and a longer
follow-up period in the NHANES-I (8 to 10 years versus 5
years, respectively). In addition, no gender-specific analyses
were included in the NHANES-I. Moreover, in a cross-
sectional analysis of the large sample of the Sleep Heart
Health Study (6000 US adults), a significantly higher
prevalence of hypertension was reported among either short
(6 hours per night) or long sleepers (9 hours per night) as
compared with the median duration of sleep of 7 to 8 hours
per night.14 However, the association was stronger among
short sleepers than in long sleepers (ie, 66% versus 30%
higher risk of hypertension, respectively). Although this
study accounted for a number of potential covariates, includ-
ing psychiatric and cardiovascular comorbidities, the cross-
sectional design does not allow us to exclude the possibility
of residual confounding by unknown variables, as well as to
exclude the potential of reverse causality. In addition, the
Sleep Heart Health Study sample cohort was, on average,
older than those in both NHANES-I and Whitehall II, thus
with a higher likelihood of geriatric comorbidities potentially
affecting sleep patterns.26
Strengths
Unlike these earlier investigations, our study examined both
cross-sectional and prospective gender-specific associations
between sleep duration and hypertension with the inclusion of
a number of potential confounding variables. Our findings
suggest a potential role of sleep deprivation in the etiology of
hypertension and other adverse health outcomes.
First, the observation that reduced duration of sleep may be
associated with a higher risk of hypertension only among
women is a novel finding. Indeed, although previous inves-
tigations have emphasized the potential impact of both short
and long durations of sleep on chronic disease risk among
women,6–9 the mechanisms underlying the gender-specific
association between sleep deprivation and hypertension, ob-
served in our study, are unknown. Given the mean age of our
female participants falling around the menopausal period
(55 years), we can speculate that the periods marking shifts
in the reproductive stages, such as menopause, are particu-
larly vulnerable times for women, because they are associated
with major hormonal turmoil and psychosocial stresses that
may, in turn, lead to adverse health outcomes.27 For example,
in our sample of female participants, the prevalence of
depression cases was higher among women reporting short
duration of sleep (5 hours per night) than in other sub-
groups. In addition, as shown in our descriptive analyses, the
distribution of correlates of short sleep duration that have the
potential to affect hypertension risk was different between
genders and may have partially contributed to the observed
associations. Finally, we cannot rule out the possibility of
differential self-reporting of sleep habits between men and
women, as suggested in a previous analysis from the Sleep
Heart Health Study examining the relationship of gender to
subjective measures of sleepiness.28
Second, although findings from cross-sectional analyses
consistently showed a strong, significant association between
short sleep duration and risk of hypertension among women,
in prospective analyses, the risk estimates were attenuated
after accounting for cardiovascular risk factors, measures of
general health, and psychiatric comorbidities. Thus, these
findings emphasize the importance of a comprehensive ex-
amination of correlates that are likely to confound or may be
on the causal pathway between sleep deprivation and adverse
health outcomes. Nevertheless, recent prospective analyses
from the Monitoring Trends Determinants in Cardiovascular
Disease Augsburg survey indicate a modest but significant
association between short sleep duration and incident myo-
cardial infarction in middle-aged women, but not men, from
the general population.29
Third, our descriptive analyses clearly demonstrate that
both short and long duration of sleep may indeed identify
population subgroups with a distinct cluster of sociodemo-
graphic characteristics, lifestyle behaviors, and disease con-
ditions that are likely to be affected by the cultural setting in
which the research is being conducted.30–33 In this regard, the
study of health consequences related to curtailments of sleep
seems to be epidemiologically relevant in the general popu-
lation, given the downward trends in the average duration of
sleep and the increasingly higher prevalence of “short sleep-
ers” in many Western countries.34,35 Conversely, it may be
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difficult for epidemiological studies to examine the health
consequences of long durations of sleep in middle-aged,
healthy populations considering the relatively low preva-
lence of “long sleepers” in the absence of overt psychiatric
comorbidities.36
Limitations
There are limitations in this study. First, the population under
investigation is an occupational cohort of white-collar work-
ers and limited to whites, which may reduce the generaliz-
ability of our findings to other populations. However, this
would not affect the internal validity of our results with
respect to the prospective analyses. Second, information
about sleep duration was self-reported by the participants.
Nevertheless, self-report assessments of sleep have been
shown to be valid measures compared with quantitative sleep
assessments with actigraphy.37,38 Moreover, because the out-
come was also assessed prospectively, any misclassification
of sleep duration would be nondifferential with respect to
incident hypertension, thus resulting in underestimation of the
true effects. A further limitation of this study is the relatively
short time of follow-up (5 years), which may have precluded
us from detecting larger and significant effects of sleep
deprivation on subsequent hypertension incidence. The
strengths of this study include the simultaneous inclusion of
a number of covariates known to be related to both sleep
patterns and hypertension. A further strength is that the
diagnosis of incident hypertension was also based on directly
measured blood pressures at both examinations, thus mini-
mizing the potential of misclassification that occurs when
using self-report alone.
Conclusions
In summary, findings from the Whitehall II cohort suggest
gender-specific associations between sleep duration and hy-
pertension risk. Specifically, cross-sectional analyses showed
a significant, consistent association between short sleep
duration (5 hours per night) and risk of hypertension only
among women, which was attenuated in prospective analyses
after multivariate adjustment.
Perspectives
Sustained sleep curtailment, ensuing excessive daytime sleep-
iness, and the higher cardiovascular risk are causes for
concern. Emerging evidence also suggests a potential role for
sleep deprivation as a predictor or risk factor for conditions
like obesity, diabetes, and metabolic syndrome not only in
adults39 but also in children.40 Further prospective studies
with improved assessment of long-term exposure (repeated
self-reported sleep duration or repeated actigraphy) and better
control for confounders are needed before causality can be
determined.
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